Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bottomly

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Nature Cancer|October 30, 2020
Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemiaHaijiao Zhang, Yusuke Nakauchi, Thomas Köhnke, et al.
Leukemia|May 6, 2020
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemiaSunil K Joshi, Jamie M Keck, Christopher A Eide, et al.
Haematologica|October 16, 2025
m6a and NuRD complexes regulate monocytic differentiation and resistance to BCL2/BCL2L1 inhibitors in acute myeloid leukemiaJackson Brim-Edwards, Karen Morris, Quinlan Morrow, et al.
British Journal of Haematology|October 20, 2022
Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemiaEvan J Barnes, Christopher A Eide, Andy Kaempf, et al.
Plos One|April 2, 2011
Evaluating gene expression in C57BL/6J and DBA/2J mouse striatum using RNA-Seq and microarraysDaniel Bottomly, Nicole A R Walter, Jessica Ezzell Hunter, et al.
BMC Genomics|August 19, 2009
High throughput sequencing in mice: a platform comparison identifies a preponderance of cryptic SNPsNicole A R Walter, Daniel Bottomly, Ted Laderas, et al.
Cancer Research|June 28, 2017
Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of FunctionHaijiao Zhang, Sophie Means, Anna Reister Schultz, et al.
Blood Advances|January 25, 2022
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemiaStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Molecular Cancer Therapeutics|May 2, 2022
Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid LeukemiaWilliam G Rice, Stephen B Howell, Hongying Zhang, et al.
Cancer Research|July 24, 2021
Lentiviral-Driven Discovery of Cancer Drug Resistance MutationsPaul Yenerall, Rahul K Kollipara, Kimberley Avila, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Nature Cancer|October 30, 2020
Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemiaHaijiao Zhang, Yusuke Nakauchi, Thomas Köhnke, et al.
Leukemia|May 6, 2020
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemiaSunil K Joshi, Jamie M Keck, Christopher A Eide, et al.
Haematologica|October 16, 2025
m6a and NuRD complexes regulate monocytic differentiation and resistance to BCL2/BCL2L1 inhibitors in acute myeloid leukemiaJackson Brim-Edwards, Karen Morris, Quinlan Morrow, et al.
British Journal of Haematology|October 20, 2022
Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemiaEvan J Barnes, Christopher A Eide, Andy Kaempf, et al.
Plos One|April 2, 2011
Evaluating gene expression in C57BL/6J and DBA/2J mouse striatum using RNA-Seq and microarraysDaniel Bottomly, Nicole A R Walter, Jessica Ezzell Hunter, et al.
BMC Genomics|August 19, 2009
High throughput sequencing in mice: a platform comparison identifies a preponderance of cryptic SNPsNicole A R Walter, Daniel Bottomly, Ted Laderas, et al.
Cancer Research|June 28, 2017
Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of FunctionHaijiao Zhang, Sophie Means, Anna Reister Schultz, et al.
Blood Advances|January 25, 2022
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemiaStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Molecular Cancer Therapeutics|May 2, 2022
Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid LeukemiaWilliam G Rice, Stephen B Howell, Hongying Zhang, et al.
Cancer Research|July 24, 2021
Lentiviral-Driven Discovery of Cancer Drug Resistance MutationsPaul Yenerall, Rahul K Kollipara, Kimberley Avila, et al.
Pageof 6